24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
When Is It Time for a Knee Replacement?AHA News: Death Rates From Tears In This Major Heart Artery Are Rising, Especially Among Women, Black AdultsOmicron COVID Causing Severe Croup in Young Children'Zapping' Air Passages May Bring Relief for Severe AsthmaModerna Asks FDA to Approve Second Booster for All AdultsNew Tick-Borne Virus Is Spreading Across U.S.Memory Issues Plague Long COVID PatientsCOVID Vaccine Won't Cause Rare Neuro Events, But COVID Infection CouldTriglycerides a Stroke Danger, Even With Statin TreatmentIt Can Take Weeks for Some Patients With Severe COVID to Recover ConsciousnessOmicron Wave Had 5 Times as Many Small Kids Hospitalized Compared to DeltaBreathing Dirty Air Could Raise Your Odds for Rheumatoid ArthritisPalliative Care Crucial After Severe Stroke, But Many Patients Miss OutMammograms Can Also Highlight Heart Risks: StudyPfizer Asks FDA to Approve Second Booster for SeniorsEven a Little Light in Your Bedroom Could Harm HealthMental Issues Can Linger More Than a Year After Severe COVIDRise in U.K. COVID Cases Closely Watched by U.S. Health OfficialsLong COVID May Bring Long-Term Lung DamageNew Malaria Treatment Gets First Approval for Use in ChildrenWarming World Means More Cases of Dangerous Low-Salt ConditionAbout 1 in 6 U.S. Couples Disagrees on COVID VaccinationCOVID Meds Appear to Work Against BA.2 Omicron Variant‘Deltacron’ Variant Rare and Not a Major ConcernCould Depression Make Dry Eye Worse?When Will Americans With Diabetes Get Relief From High Insulin Prices?COVID's Global Death Toll May Be 3 Times Official NumbersDrug Could Be Non-Antibiotic Alternative to Treat UTIsFlu Vaccine No Match for Circulating Variants This SeasonLymphedema in Legs Strikes 1 in 3 Female Cancer SurvivorsScience Brings Shortcut to Spotting 50 Rare Genetic DiseasesU.S. Airplane, Train and Transit Mask Mandates Extended to April 18Man Who Received First Pig Heart Transplant Has DiedPfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17Could a Stool Test Help Spot Pancreatic Cancer?Upcoming Surgery Worry You? Poll Says You're Not AloneHalf of Americans Live With Legacy of Childhood Lead PoisoningIn Reversal, WHO Now Supports COVID BoostersLooking to Neanderthals to Explain Today's Lower Back PainWhat's More Accurate, Blood Pressure Readings at Home or Doctor's Office?Begin Now to Protect Your Heart as Clocks 'Spring Forward'Brain Changes May Fuel 'Long COVID' Anxiety, ConfusionAHA News: Break Up Binge-Watching by Taking a StandHow COVID-19 Can Change the BrainHeart Defects Could Raise Odds for Severe COVID-196 Healthy Steps to Preventing Colon CancerAHA News: These Three Risk Factors May Have the Biggest Impact on Dementia CasesU.S. Surgeon General Investigates COVID-19 MisinformationLong or Irregular Periods May Put a Woman's Liver at RiskCould Your Blood Type Make COVID Worse?
Questions and AnswersLinks
Related Topics

Diabetes

Almost 1 in 10 U.S. Lung Transplants Now Due to COVID

HealthDay News
by Robert Preidt
Updated: Jan 27th 2022

new article illustration

THURSDAY, Jan. 27, 2022 (HealthDay News) -- COVID-19 is changing medicine in yet another way: A new study finds that patients with COVID-related lung damage now account for nearly one in 10 lung transplants in the United States.

The researchers analyzed data on more than 3,000 lung transplants nationwide between Aug. 1, 2020, and Sept. 30, 2021. They found that 7% of them were performed to treat severe, irreversible lung damage caused by COVID-19.

The average age of the 214 COVID lung transplant patients was 52, and the rate of three-month survival was nearly 96%.

The findings showed that 140 patients had COVID-19 acute respiratory distress syndrome, and 74 patients had COVID-19 pulmonary fibrosis.

"Acute respiratory distress syndrome involves an acute inflammation of the lungs, resulting in decreased ability for the lungs to oxygenate and ventilate," said study co-author Dr. Amy Roach. She's a general surgery resident and research fellow at Smidt Heart Institute of Cedars-Sinai Medical Center in Los Angeles.

"In some patients this progresses to COVID-19 pulmonary fibrosis, which causes scarring in the lung and is generally irreversible," Roach said in a medical center news release.

More than half of the 214 patients required ventilators or extracorporeal membrane oxygenation (ECMO) before their transplant, according to the study. The results were published Jan. 26 in the New England Journal of Medicine.

Study co-author Dr. Joanna Chikwe said, "Our experience treating COVID-19 has shown us that ECMO can be used in carefully selected patients, either as a bridge to lung transplantation, or to allow a patient's own lungs to heal." Chikwe is chair of the heart institute's department of cardiac surgery.

"Most of these COVID-19 patients would have been considered too ill to transplant a few years ago, and the surprising finding of our research was how well they did after lung transplantation," she added.

ECMO involves pumping a patient's blood from the body and through an artificial lung before being returned to the body.

Between July 2020 and June 30, 2021, Cedars-Sinai provided more than 30,000 hours of ECMO care to patients. Of those, 21,000 hours were for patients with severe lung disease due to COVID-19.

More information

For more on how COVID-19 affects the lungs, visit the U.S. National Heart, Lung, and Blood Institute.

SOURCE: Cedars-Sinai Medical Center, news release, Jan. 26, 2022